Health and Healthcare Systems

From competition to collaboration: How secure data sharing can enable innovation

Graphic visualisation of data.

Image: Unsplash.

Hugo Ceulemans
Scientific Director, Discovery Data Sciences, Janssen Research & Development, Janssen Pharmaceutica NV, Johnson & Johnson
Tinne Boeckx
Contract and grant project manager, Senior Life Sciences consultant, Avertim
Share:
Our Impact
What's the World Economic Forum doing to accelerate action on Health and Healthcare Systems?
The Big Picture
Explore and monitor how Data Science is affecting economies, industries and global issues
A hand holding a looking glass by a lake
Crowdsource Innovation
Get involved with our crowdsourced digital platform to deliver impact at scale
Stay up to date:

The New Data Economy

  • COVID-19 has necessitated a more collaborative way of working across sectors.
  • Healthcare has been at the forefront of this shift and we must build on this momentum.
  • Open data sharing can facilitate innovation and power a sustainable economic recovery.

Today’s economy is fundamentally driven by data – we already have more bytes than there are stars in the observable universe. Businesses are required to rapidly adopt technology to utilize this data and improve products and services.

This challenge has been dramatically amplified by COVID-19, creating a global health crisis as well as a supply and demand shock in many industries. While market forces will eventually bring back equilibrium, this may take years and have a significant negative social and economic impact, calling for novel mitigation strategies and innovation in business across industries.

Have you read?

Seventy-six percent of business executives agree that innovation requires new ways of collaborating with ecosystem partners and third-party organizations. This article is a pledge for out-of-the-box-thinking in business, healthcare and beyond, where competition and collaboration go hand in hand as "coopetition".

New opportunities for data-driven value creation. Source: World Economic Forum.
New opportunities for data-driven value creation. Source: World Economic Forum.

Combining confidentiality and open-source

For many business leaders, collaboration equals data sharing. A research report by the European Commission on B2B data sharing cited fear of data privacy breaches as the main barrier to making data available to others, resulting in costly missed business opportunities. Indeed, collaboration is often associated with mistrust and concerns about losing control over data. Yet, given today’s technologies, is this really still a valid concern? What if businesses could get out of the "data gridlock" and collaborate without the risks associated with data sharing?

Decentralised approaches for collaborative data use are one of the top strategic technology trends for 2021, according to Gartner. Such technologies make data aggregation on a central server unnecessary – reducing the risk and cost of moving sensitive data from its original location and thus protecting data confidentiality and IP.

Our relationship to technology is changing from protectionism to democratization.

Hugo Ceulemans.

Even our relationship to technology is changing from protectionism to democratization. Today, whilst investing in proprietary IP is still valuable, businesses are increasingly recognizing the value of open-source and sharing insights. Contributing to open-source tools means putting transparency first while simultaneously fueling fast-paced innovation and building trust with stakeholders. Software giants such as IBM have endorsed open-source initiatives for some time now. The Linux Foundation, for instance, fosters open technology ecosystems and provides a platform for developing industry-wide data standards and governance. This promotes interoperability and supports businesses with cloud-native transformation.

Making a case for coopetition

Our biggest societal challenges cannot be tackled in isolation. From climate change and health crises to poverty and social exclusion – collaboration is essential. Coopetition is one such strategy: cooperating with competitors to multiply knowledge, skills and resources without losing your competitive edge.

Whilst some might not be comfortable with the thought of multiple winners, it is worth considering the risks of not taking a cooperative opportunity: delaying breakthrough discoveries, overlooking new markets, missing out on cost savings by duplicating efforts, or simply the risk of there being no winner at all. “Co-opetition requires mental flexibility, but firms that develop it can gain an important edge." Harvard Business Review.

The number of use cases for coopetition is growing. In 1997, Apple and Microsoft famously announced a previously unthinkable strategic partnership that allowed Microsoft software to run on Apple devices. Both tech pioneers recognized the potential of unlocking new market opportunities outweighed the risk of going solo.

“We have to let go of this notion that for Apple to win, Microsoft has to lose.” Steve Jobs said at the 1997 Macworld Expo.

Tesla, more recently, chose to apply an open-source philosophy to their patents by announcing it “will not initiate patent lawsuits against anyone who, in good faith, wants to use our technology”. Competitors and the general public alike are stimulated to innovate and adopt electric vehicle technology. IMEC’s business model is another example of digital technology and nanoelectronics experts joining forces to build an open innovation model, keeping R&D costs low for its industry partners.

Coopetition in healthcare

Ripe for coopetition is healthcare, on account of the complexity of unmet medical needs, the sensitivity of health data accompanied by stricter regulations, and the staggering investment requirements. On average, it takes 13 years and €1.9 million of investment to bring a new drug to market. New paradigms are, therefore, vital to bringing down costs.

It is well known that pharmaceutical companies have accumulated immense proprietary data warehouses, representing an untapped source of information across data types. Imagine that the pharmaceutical industry could leverage each other’s data to build more powerful predictive models for drug discovery without compromising data and model privacy. What could this enable?

MELLODDY (Machine Learning Ledger Orchestration for Drug Discovery) is the first of its kind where the pharmaceutical industry is embarking on the journey of coopetition with the help of technology experts. This flagship project brings together 10 pharmaceutical companies to advance drug discovery using a decentralized and data-private machine learning technology called federated learning, built on open-source software.

In 2020, MELLODDY met its first milestone of successfully training a model at scale. The consortium is now working to prove that models can be more effective when trained on data across multiple institutions, demonstrating that coopetition is not only possible but beneficial for all involved. Beyond benefitting the drug discovery field with better predictive models, MELLODDY serves as a foundational case study for industry-wide coopetition and data challenges, combining open-source and confidentiality-preserving approaches to advance technological progress.

Discover

How is the World Economic Forum bringing data-driven healthcare to life?

Knowledge sharing is the future

In game theory, positive-sum games are situations in which no one wins at the expense of others, yet the collective knowledge and resources will have grown. Coopetition is one such win-win situation. The continuous development of distributed learning projects with state of the art technologies has the potential to demonstrate that big data challenges, sensitive information and fragmented data ownership within competitive industries can indeed be solved collaboratively.

We invite business leaders to ask themselves: which major socioeconomic or industry challenges can be solved by sharing knowledge and combining insights with my competitors? The opportunity is here today to shift our thinking and dare to execute new paradigms for collaboration.

Don't miss any update on this topic

Create a free account and access your personalized content collection with our latest publications and analyses.

Sign up for free

License and Republishing

World Economic Forum articles may be republished in accordance with the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International Public License, and in accordance with our Terms of Use.

The views expressed in this article are those of the author alone and not the World Economic Forum.

Share:
World Economic Forum logo
Global Agenda

The Agenda Weekly

A weekly update of the most important issues driving the global agenda

Subscribe today

You can unsubscribe at any time using the link in our emails. For more details, review our privacy policy.

Scientists make pancreatic cancer discovery, and other top health stories to read

Shyam Bishen

July 17, 2024

About Us

Events

Media

Partners & Members

  • Sign in
  • Join Us

Language Editions

Privacy Policy & Terms of Service

© 2024 World Economic Forum